JPRN-UMIN000036159尚未招募未知
Efficacy of pre operative Tegafur/Uracil and Degarelix combination therapy for high risk prostate cancer - Efficacy of pre operative Tegafur/Uracil and Degarelix combination therapy for high risk prostate cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •Patient who is difficult to obtain his consent.
研究者
相似试验
已完成
2 期
A phase II study with Tegafur/Uracil and Peg-Interferon after TACE for hepatocelluler carcinomaAdvanced hepatocellular carcinomaJPRN-C000000275The third department of Internal Medicine, Wakayama Medical University20
招募中
2 期
Clinical trial on the QOL of the Tegafur/Uracil plus Leucovolin(UFT/LV) to adjuvant chemotherapy for the Stage II, III colorectal cancerresectable StageII, III colorectal cancerJPRN-UMIN000008961Department of Surgery Keio University School of Medicine400
已完成
2 期
UFUR Plus Thalidomide for Advanced Hepatocellular CarcinomaHepatocellular CarcinomaNCT00519688National Taiwan University Hospital44
尚未招募
4 期
Comparing the effectiveness of nebulization dexmedetomidine and lignocaine on control of hemodynamic response to laryngoscopy and intubatioCTRI/2024/07/071554Department of Anaestesiology
Unknown
2 期
A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC)Carcinoma, HepatocellularNCT00384800Far Eastern Memorial Hospital41